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The acknowledgment of antimicrobial resistance (AMR) as a major health challenge
in humans, animals and plants, has led to increased efforts to reduce antimicrobial
use (AMU). To better understand factors influencing AMR and implement and evaluate
stewardship measures for reducing AMU, it is important to have sufficiently detailed
information on the quantity of AMU, preferably at the level of the user (farmer, veterinarian)
and/or prescriber or provider (veterinarian, feed mill). Recently, several countries have
established or are developing systems for monitoring AMU in animals. The aim of this
publication is to provide an overview of known systems for monitoring AMU at farm-level,
with a descriptive analysis of their key components and processes. As of March 2020,
38 active farm-level AMU monitoring systems from 16 countries were identified. These
systems differ in many ways, including which data are collected, the type of analyses
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conducted and their respective output. At the same time, they share key components
(data collection, analysis, benchmarking, and reporting), resulting in similar challenges
to be faced with similar decisions to be made. Suggestions are provided with respect
to the different components and important aspects of various data types and methods
are discussed. This overview should provide support for establishing or working with
such a system and could lead to a better implementation of stewardship actions and
a more uniform communication about and understanding of AMU data at farm-level.
Harmonization of methods and processes could lead to an improved comparability of
outcomes and less confusion when interpreting results across systems. However, it is
important to note that the development of systems also depends on specific local needs,
resources and aims.
Keywords: antimicrobial use, livestock, overview, indicator, benchmarking, monitoring, antimicrobial stewardship,
antimicrobial resistance
INTRODUCTION
Antimicrobial resistance (AMR) is acknowledged as one of the
main threats to human health worldwide. It is widely recognized
that antimicrobial use (AMU) leads to the selection of resistant
bacteria (1), and that animals may constitute one of the reservoirs
of resistant bacteria and resistance genes (2–4). Recently, an
association between the use of certain antimicrobials in animals
and the occurrence of AMR in certain clinical isolates from
humans has been shown (5–7). Consequently, reducing AMU in
both humans and animals is an essential step toward limiting the
prevalence of AMR in both humans and animals.
At the end of the previous millennium, the concept of
antimicrobial stewardship (AMS) was established as a set of
“responsible use” policy measures aimed at combatting AMR in
human hospitals (8). AMS programs have since become common
tools in human medicine (9). Following an increased focus on
“One Health”; which emphasizes the interconnection between
human, veterinary and environmental health, the need for more
prudent use practices in veterinary medicine has become more
widely accepted, i.e., using antimicrobials “only when necessary”
and with treatment decisions based on the diagnosis, including
pathogen and relevant resistance data (10).
Collection of reliable AMU data is crucial for the
establishment of AMS programs and to measure their
effectiveness. In veterinary medicine, major steps have been
taken in many countries regarding the development and
implementation of systems for collecting national sales
data of antimicrobial medicinal products. At the European
Union (EU)/European Economic Area (EEA) level, these
data are collated by the European Surveillance of Veterinary
Antimicrobial Consumption (ESVAC) project at the European
Medicines Agency (EMA). The latest ESVAC report included
sales data from 31 countries (11), having increased from nine
countries in the initial ESVAC report (12). Data is provided
voluntarily to ESVAC. In the future collecting data on the
volume and use of antimicrobials will become mandatory
for EU member states (13). The data published in ESVAC
reports has been shown to be important for policymaking,
including AMS at the national level, such as setting targets for
reducing overall sales and, in particular, of critically important
antimicrobials (CIAs). However, accurately determining AMU
by animal species using sales data is complicated by the fact
that VMPs are labeled for use in multiple species and often
used off-label in other species. Furthermore, antimicrobial sales
quantification typically does not take dosing differences between
antimicrobials into consideration. Moreover, availability of
reliable AMU data at the level of the end-user and/or prescriber
or provider of the medicinal products (farmer, veterinarian,
pharmacies, or feed mills), is vital for guiding farm- and/or
sector-specific AMU practices (14–16), targeting unnecessary
or inappropriate use, encouraging improvements in animal
husbandry, disease prevention and control, and enabling
detailed risk and trend analyses.
Many countries are at the initial or advanced stages of
setting up systems for monitoring AMU at farm-level by animal
species in all or some (food-producing) animal species. Setting
up such systems involves various challenges to be faced and
decisions to be made, for example, how to organize the data
collection, the type and detail of the collected data, choice
of indicators for reporting results, benchmarking criteria for
acceptable or non-acceptable use, etc. The aim of this paper
is to describe known farm-level AMU monitoring systems
and discuss their key components and processes. This should
provide support for establishing or working with a system and
lead to a better implementation and evaluation of stewardship
measures. Furthermore, it could be a step toward an improved
understanding and sharing of knowledge as well as a more
uniform communication across systems and countries. This
would make it easier to identify and understand the effects of
factors influencing AMU, such as animal health status, presence
or absence of certain diseases, biosecurity levels, vaccination
programs, historically developed practices, cultural differences,
etc., and ultimately, AMR.
This paper was written within the framework of the
AACTING project (a Global “network on quantification of
Antimicrobial consumption in animals at farm-level and
Analysis, CommunicaTion and benchmarkING to improve use”),
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which was funded by the Joint Programming Initiative on
Antimicrobial Resistance (JPI-AMR, project number 270610). A
detailed overview of the characteristics of the current systems in
each country is available on the AACTING website1.
OVERVIEW OF EXISTING SYSTEMS FOR
AMU MONITORING AT FARM-LEVEL
As of March 2020, 38 active farm-level AMU monitoring
systems (further referred to as “systems”) from 16 countries were
identified by the authors. Figure 1 lists all systems, including
inactive systems, by year of official implementation and, if
applicable, stratifies them by animal species. The oldest systems
are those of the Swedish Board of Agriculture (SBA) and the
Danish VetStat monitoring tool. Since 2010, many new systems
have been set up in many countries and several existing systems
were extended to additional animal species. As shown in Table 1,
pigs and broilers are most frequently monitored, followed by
calves and dairy cows.
Three general features of the systems merit closer attention.
The first is coverage, i.e., the proportion of the animal population
included from the animal sector(s) targeted by a system. The
identified systems can be divided into sample surveys (N = 11),
partial coverage systems (N = 15), and full coverage systems
(N = 12) (Figure 1). Full coverage systems aim to include all
farms in an animal sector. Partial coverage systems include
a substantial part of a sector, often on a non-random and
possibly compulsory basis (e.g., adherence to a quality assurance
scheme). For example, in the UK using the eMB-pigs system is
a requirement under the farm assurance scheme “Red Tractor,”
which represents 94% of UK pig farms. Sample surveys target
a small and ideally random and representative sample of a
sector. Alternatively, stratified sampling can be applied and,
by weighting the results by stratum, a representative result for
AMU in a sector can be obtained. Sample surveys are often
intended to estimate the AMU within the sector and/or can be
pilots to gain knowledge for establishing monitoring systems
with broader coverage. For example, the MARAN data collection
system in the Netherlands was used as the basis for the sector
quality assurance systems that at present provide full coverage
AMU monitoring (17). Participation in these systems can be
a requirement for farmers to allow access to certain markets
or customers. The German “VetCab” sample survey was the
pilot for the implementation of the module for AMU in the
“HIT” system and is now used to collect data for detailed
analyses and to test options for methodological changes (18).
The “HIT” system collects AMU data for almost all food-
producing animal farms (although selection criteria on farm size
are applied for major fattening livestock species). In France, the
“INAPORC” surveys will continue to be used until the “GVET”
monitoring system is more widely implemented (19). In the
Czech Republic, pilot schemes are currently being used to plan
for the establishment of broader systems later. Furthermore, in
Italy data from the national electronic prescription system, which
1www.aacting.org
became mandatory in May 2019, is currently under processing
and it will be used to improve 2020 pharmacosurveillance
controls in pigs, cattle, and poultry. Despite their relatively
limited scope, sample surveys can inform decision making,
ideally when a representative sample is reached. In Canada,
for example, data from a sample of sentinel farms was used to
eliminate the preventive use of ceftiofur and fluoroquinolones in
the poultry sector, as well as to reduce the use of some nationally
defined medically important antimicrobials (20).
A second general aspect of the systems is their main funder,
being either “private” or “governmental.” This is relevant for
the “management role” in a system (i.e., who is operating the
system?), as well as data ownership. Figure 1 shows that most
systems are primarily government funded. Some systems, e.g.,
CLIPP in France, are jointly funded by private organizations and
the government. Private organizations include quality assurance
organizations, industry levy boards, or professional bodies.
When combining coverage and funding, it appears that the
government is the main funder for most sample survey and full
coverage systems. In contrast, private organizations are the main
funders of almost all currently existing partial coverage systems.
These systems generally target only farms that adhere to the
respective quality assurance scheme and/or professional bodies.
The third general aspect, linked to coverage and funding, is
the participation in the system, which can be “voluntary” or
“compulsory” (Figure 1 and Table 1). Most systems with full
coverage are compulsory, primarily by law/regulations. Several
partial coverage systems are also compulsory as a requirement
of quality assurance schemes. Caution should be exercised when
interpreting data or extrapolating results from voluntary systems
as these may represent the more conscientious and proactive
farmers, and usually cannot be regarded as being representative
of the population at large.
ANALYSIS OF KEY COMPONENTS AND
PROCESSES OF MONITORING SYSTEMS
FOR FARM-LEVEL AMU
Four key components were distinguished for farm-level AMU
monitoring systems: (1) data collection and quality control, (2)
data analysis, (3) benchmarking, and (4) reporting.
Data Collection and Quality Control
Data collection includes the process of entering raw data into the
data collection system. Within the specific scope of monitoring
farm-level AMU data, some aspects are particularly relevant.
At least two types of data need to be collected per identified
farm: use data (also referred to as the “numerator,” see section
“Data analysis”) and the animal population to standardize the
use data (also referred to as the “denominator,” see section “Data
analysis”). Use does not always constitute real administration
of antimicrobials to animals; prescriptions, deliveries or sales at
farm-level are often the only convenient data-source in practice.
It is essential to record the time of use or date of delivery,
in order to allocate the AMU to a certain time interval (see
section “Benchmarking”).
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FIGURE 1 | Data collection systems in each country, shown by start year of data collection and divided according to the coverage of the sectors included in each
system (see “LEGEND”). A species below a system name is to indicate that the species was included in the system from that year on; no species indicated has no
specific meaning—see further in the text for information on which species are covered in each system.
Data collection can be automatic or manual. The former
means the data are delivered digitally through software-linked
data sources, e.g., from veterinary practice or farm management
software, while the latter requires the data to be actively entered,
e.g., by typing into an online interface, using prescription sheets,
medicine books, as the data source. A pragmatic approach for
data input is to offer both an automatic and a manual option.
Automatic input will reduce the risk of typing errors and will
significantly reduce the administrative burden for the parties
providing the data. However, automatic input and transfer may
require investment, training, and an adjustment of existing
software. Manual input and transfer may therefore be offered as
an alternative. In addition, if mistakes occur, manual correction
of the automatic data input should be possible. When allowing
manual retrospective corrections, a time-lock for accepting such
changes should be considered, after which data entry cannot
be altered by primary users. Allowing traceability of subjects
uploading as well as altering the data is also considered useful.
Data input in general (including “new” data) could be subjected
to a time-lock, after e.g., a 1-year period. This may trigger users
to frequently interact with the system and prevents continuous
changes in the outcomes of the analyses, which is not desirable
as the data might also be used for trend analysis and future
calculations of AMU indicators. Note that a time-lock should
not preclude correction of data errors. System administrators
should always have the possibility to correct data errors, e.g.,
when obvious discrepancies are identified, and data quality could
be considerably improved. In addition to using a time-lock, a
logging systemwill be indispensable for enabling follow-up of the
data-input. Data logs are useful for retrieving facts and figures for
later analyses and for quality assurance.
To minimize the risk of data manipulation, careful
consideration is required when determining which parties
are authorized to alter the data, and which changes are allowed.
Authority for alterations could, for example, be given only for
data that the party has provided. Additionally, or alternatively,
“party-over-party” checks could be required before accepting
changes. For example, if the veterinarian provides the number
of medication packages delivered and the farmer is permitted
to make changes to that number, then the system might
require final approval from the veterinarian. By imposing
quality checks upon data input, the need to alter data at a later
stage—and possible problems associated with such changes
(e.g., changed benchmarking results)—might be avoided or
minimized. This can be done by defining mandatory information
to be included and running plausibility checks before the
dataset can be submitted. Requiring active confirmation of
a farmer that their data are correct might also be an option.
This approach is particularly relevant for parties that actively
register zero AMU, in order to distinguish true zero-users
from farms with incorrect data or non-active farms. In the
Belgian AB Register, farms that do not report any use over a
certain period, without confirming this, are targeted by certified
control agencies.
A quality check can also be implemented after sending
the data. Standard quality measures should include plausibility
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TABLE 1 | Core characteristics of the currently existing systems for farm-level data collection of antimicrobial use data.
Countrya–system Collection
Animal typeb Input of
AMU datac
Compulsory
byd
Austria PHAROS Pi Da Be Ca Br La Tu Go Sh Vet Legislation
Austria PHD Br La Tu Vet QAS
Belgium AB Register Pi Da Br La Tu Vet·FM·PH QAS
Belgium BIGAME Pi Da Be Ca Br La Go Sh Vet QAS ·
voluntary
Belgium Sanitel-Med Pi Ca Br La Vet Legislation
Belgium SGS-BVK Ca Vet QAS
Canada CIPARS Pi Br Tu Farmer·Vet NA: survey
Canada FAOC Fi Farmer Legislation
Czech Republic DLN cattle Da Farmer·Vet NA: voluntary
Czech Republic Q VET pigs Pi Farmer NA: voluntary
Denmark VetStat Pi Da Be Ca Br La Tu Go Sh Fi Ot:
Mi
Vet·FM·PH Legislation
Finland AH ETT poultry Br Tu Vet NA: voluntary
Finland SIKAVA Pi Farmer·Vet QAS
France CLIPP Ot:
Ra
Farmer·Vet·TN NA: voluntary
France GVET Pi Farmer NA: voluntary
France INAPORC Pi Farmer·Vet·
FM·TN
NA: survey
France RefA²vi Br Tu Ot:
**
Farmer·Vet NA: voluntary
France VEAL Ca Farmer·Vet NA: voluntary
Germany HIT Pi Be Ca Br Tu Farmer·Vet Legislation
Germany QS Pi Ca Br Tu Ot:
Du
Vet QAS
Germany VetCAb-ID Pi Da Be Ca Br La Tu Go Sh Ho Fi Pe Ot Not specified Not specified
Germany VetCAb(-S) Pi Da Be Ca Br Farmer·Vet NA: survey
Ireland Teagasc Pi TN NA: survey
Ireland Nat. DB pigs Pi Farmers QAS
Italy ClassyFarm Pi Da Ca Br La Tu Researcher NA: survey
Netherlands SQS|SDa Pi Da Be Ca Br Tu Ot:
Ra
Vet QAS
Netherlands SDa* Go Sh Ho Pe Ot:
Mi
Vet NA: survey
Norway VetReg Pi Da Be Ca Br La Tu Go Sh Ho Fi Pe Ot:
De
Vet·FM·PH Legislation
Spain NDVAP Pi Da Be Ca Br La Tu Go Sh Ho Vet Legislation
Sweden SBA Pi Da Be Ca Br La Tu Go Sh Ho Fi Ot:
#
Vet Legislation
Sweden SPMA Br Vet QAS
Switzerland IS ABV Pi Da Be Ca Br La Tu Go Sh Ho Fi Pe Ot:
Ra
Vet Legislation
Switzerland SuisSano|Safety + Pi Farmer QAS
United Kingdom BEIC La Farmer QAS
United Kingdom BPC-AS Br Tu Ot:
Du
Vet PB
United Kingdom eMB-Pigs Pi Farmer·Vet·FM QAS
United Kingdom GFA Ot:
Ga
Vet·FM NA: voluntary
United Kingdom SSPO Fi Vet NA: voluntary
(Continued)
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TABLE 1 | Continued
Countrya–system Analysise Benchmarkingf Reporting at farm
level (Y/N)f
Weight-based Dose-based Count-based Y/N Parties
Austria PHAROS – DDDvet – Y (Farmers) Vets N
Austria PHD mg – Herds Y Farmers Y
Belgium AB Register – DDDAbel – Y Farmers Y
Belgium BIGAME mg/kg DDDAbel – Y Farmers Y
Belgium Sanitel-Med mg/kg DDDAbel – Y Farmers·Vets Y
Belgium SGS-BVK – DDDAbel – Y Farmers Y
Canada CIPARS mg/PCU DDDvetCA Flocks/herds N Y
Canada FAOC mg N Y
Czech
Republic
DLN cattle mg – – Y Farmers Y
Czech
Republic
Q VET pigs – ADD – Y Farmers Y
Denmark VetStat – ADD – Y Farmers Y
Finland AH ETT poultry – – Flocks N N
Finland SIKAVA – – – (Y) N
France CLIPP – – Days Y Farmers Y
France GVET mg UDD·UCD·DDD
(vet) ·DCD(vet)
Days/animals Y Farmers Y
France INAPORC mg DDD(vet)·DCD
(vet)
– N Y
France RefA²vi – DDDFR·DCDFR – N Y
France VEAL mg/animal DCDFR Days/animals N Y
Germany HIT – – Days/animals Y Farmers Y
Germany QS – – Days/animals Y Farmers Y
Germany VetCAb-ID – – Days/animals N N
Germany VetCAb(-S) – – Days/animals N Y
Ireland Teagasc mg/kg – – Y Farmers Y
Ireland Nat. DB pigs mg/kg – – N Y
Italy ClassyFarm – DDDAIT – Y Farmers Y
Netherlands SQS|SDa – DDDANL – Y Farmers·Vets Y
Netherlands SDa* – DDDANL – N N
Norway VetReg mg – – N N
Spain NDVAP mg – N N
Sweden SBA – – – N N
Sweden SPMA – – Flocks N N
Switzerland IS ABV – PDD·DDDvet·DCDvet Animals (Y) Farmers·Vets (Y)
Switzerland SuisSano|Safety + – DCDvet·DCDCH Animals Y Farmers Y
United Kingdom BEIC – ADD – N N
United Kingdom BPC-AS mg/kg – – N N
United Kingdom eMB-Pigs mg/kg – – Y Farmers N
United Kingdom GFA mg – – N N
United Kingdom SSPO mg/kg – – N N
aAT, Austria; BE, Belgium; CA, Canada; CH, Switzerland; CZ, the Czech Republic; DE, Germany; DK, Denmark; FI, Finland; FR, France; IE, Ireland; IT, Italy; NL, the Netherlands; NO,
Norway; SE, Sweden; SP, Spain; UK, United Kingdom.
bPi, pigs; Da, dairy cattle; Be, beef cattle; Ca, calves (veal and/or conventional); Br, broilers; La, laying hens; Tu, turkeys; Go, goats; Sh, sheep; Ho, horses; Fi, fish; Pe, pets; Ot, other,
which can be De, (rein)deer; Du, ducks; Ga, game birds; Mi, mink; Ra, rabbits; in case of the SBA system in Sweden, #stands for geese, ostriches, mink and reindeer, *stands for all
poultry production species including duck, guinea fowl, pigeon.
cVet, veterinarian; FM, feed mills; PH, pharmacies; TN, technician.
dNA, not applicable; PB, Professional Body; QAS, quality assurance scheme.
eADD, animal daily dose; DDDAbel , defined daily dose for animals as defined for Belgium; DCDCH, defined daily dose for animals as defined for Switzerland; DCDIT , defined course dose
for animals as defined for Italy; DDDFR/DCDFR, defined daily/course dose for animals as defined for France; DDDANL, defined daily dose for animals as defined for the Netherlands;
DDDvet/DCDvet, defined daily/course dose for animals as defined by EMA (EMA, 2015); DDDvetCA, defined daily dose for animals as defined for Canada; PCU, population correction
unit, as defined by EMA (EMA, 2011); PDD, prescribed daily dose; UCD, used course dose; UDD, used daily dose; DCD, defined course dose.
fY/N, yes/no; (Y), planned for the (near) future.
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checks of whether the reported variables are within the expected
range, whether the identification numbers of core-variables are
unique and whether the combination of categories is valid. In
the latter case, for example, age groups, and disease groups
should match the intended animal species, e.g., weaners should
always be recorded in the animal category “pig” while the
disease “goldfish ulcer disease” should only apply to “fish.” By
processing the data into the anticipated result or by cross-
checking with corresponding information in other databases or
previous submissions, suspected mistakes can also be identified.
After this checking step, validation should be requested, for
example, by requiring additional (manual) confirmation or
requiring input of the corrected data instead. For example, in
the Netherlands, quality systems are notified of outliers by the
Netherlands Veterinary Medicines Institute, and confirmation or
correction is requested.
Use Data
For use data some specific aspects apply. Restricting and/or
standardizing the options per input field will help to improve
data quality. For example, in the Netherlands, a template is
sent to the respective sector quality systems, which states the
variables to be reported and their range. In the French “GVET”
system, drop-down lists are included in the software and farmers
select the veterinary medicinal products from a standardized
list of all products authorized in France, where all medicines
are linked with a unique identifier. They then choose one
of the pre-set units of dosage (g/animal or g/100 kg of body
weight for example) and there are also lists for other treatment
characteristics (dates of administration, duration, indication,
etc.). A similar approach is used in the Swiss system “IS-ABV.”
The variables collected for the use data are dependent on the
AMU indicator being calculated (see section “Data analysis”). As
an example, the variables required in the Netherlands for the use
data include the farm identification number, the delivery date of
the antimicrobials, the European Article Number (EAN) of the
antimicrobial and the number of packages delivered. The EAN is
an identification number which is unique for every antimicrobial
sold. In a database all antimicrobials used in livestock are
recorded. This database also contains information on dosages (by
animal species), administration routes, antimicrobial class, active
ingredient(s), etc.
Animal Population Data
Depending on the AMU indicator being calculated, different
types of animal population data can be collected (see section
“Data analysis”). Within animal species, several animal categories
can be distinguished to further refine AMU monitoring. For
example, in Denmark and the Netherlands, three animal
categories are defined for pigs: sows and piglets, weaned piglets
and finishing pigs (21, 22). Animal population data per farm
can be obtained internally or externally. Internally means that
the data are collected specifically for the purpose of analyzing
AMU data. For example, the monitoring system might require a
farmer to provide the number of animals present (by production
category) on his or her farm or the veterinarian might be
required to record the number of animals on the farms
visited. Regular inspections to obtain animal counts are also
a possibility.
Externally acquired population data originate from sources
established for purposes other than analyzing AMU data,
typically not owned or managed by the AMUmonitoring system,
such as animal population data collected for epidemiological
surveillance, for allocation of grants or for manure accounting.
In the French GVET, for example, data from “GTE” is used,
another French system whose goal is to yield technical-economic
results to farmers. Data of produced biomass might also be
obtained from slaughterhouses, which would have to register
the number of animals slaughtered by farm. To improve data
quality and for data management in general, it is advisable
to minimize the number of “external” data sources. However,
in many of the existing systems, animal population data are
provided from external sources. In several systems, this is known
to cause problems with retrieving updates or resolving problems
in a timely manner. For example, in the Netherlands animal
population data retrieved from the Central Board of Statistics
were not always in line with animal population data collected
by livestock sectors. Also updates in animal population data
occurred after the annual report on AMU in the Dutch livestock
sectors, leading to corrections in AMUfigures after publication of
the report. In Belgium, the SANITEL database for identification
and registration of food producing animals does not contain
animal numbers of all animal categories monitored in the
AMU data collection systems. Furthermore, for several farms,
SANITEL data are found to be incomplete or not up-to-date.
Additional data can be collected to allow for more detailed
analysis and refinedAMS. For example, use by animal production
stage or type, the weight at treatment, indication(s) for treatment,
and/or the prescribing veterinarian, type of administration (e.g.,
treatment, metaphylaxis, and prophylaxis) etc. However, the
requested input should be of relevance to the analyses that will
be carried out. Requesting too much or too detailed information
will result in an unnecessarily high workload for the data provider
and might lead to a subsequent lack of engagement.
It is also important to consider whether the data requires
transformation prior to calculating AMU. For example, data on
use of feed mixed with antimicrobials can be obtained directly
by requesting the amount of premix delivered/mixed into the
feed, or by requesting the amount of medicated feed delivered
while also providing information on the concentration of premix
in the medicated feed. Requesting untransformed data ensures a
uniform calculation of AMU and is therefore preferred.
More practical information on data collection is provided in
the guidelines (see AACTING website).
Data Analysis
Data analysis is conducted to establish the farm-level AMU.
Three important aspects of this calculation exist: selection of
unit of measurement (UM), the animal population at risk (or
denominator) and the indicator (Tables 1 and 2).
Unit of Measurement
The UM is the unit in which the numerator is expressed. It
can be mass-based, dose-based or count-based. Mass-based UMs
express the numerator as milligrams, kilograms or tons (i.e.,
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metric tons) of the active substance. Dose-based UMs express
the numerator as the number of doses with several types being
distinguished, e.g., defined daily dose animal (DDDA), used daily
dose animal (UDDA), prescribed daily dose animal (PDDA),
or defined course dose animal (DCDA) [(23–25); Table 2].
Typically, a dose-based UM is calculated from the amount
of active ingredient using a mass-based UM. For example, if
two 250ml bottles of a medicinal product with one active
antimicrobial substance at a concentration of 80 mg/ml have
been used, a mass-based numerator indicates that 40,000mg
of active substance has been used. If these bottles have been
used according to a prescription stating 8 mg/kg bodyweight per
day, then a corresponding dose-based numerator indicates 5,000
PDDAs have been used (40,000/8= 5,000).
For a count-based UM, the numerator can express the number
of treatment days or treatment courses. Using the example above,
if the medicinal product was used to treat a batch of 100 animals
for 5 days, then the numerator would be 500 treatment days
or 100 treatment courses. Hence, a count-based UM does not
require data on the actual amount of antimicrobials used. It is
worth noting that if, in the example given, each animal weighed
∼10 kg and the prescribed dose of 8 mg/kg bodyweight per day
was given, then this will correspond to a mass-based numerator
of 40,000mg of active substance used (100∗10∗5∗8= 40,000) and
a dose-based numerator of 5,000 UDDAs (40,000/8 = 5,000).
These examples illustrate that, although they have a different
meaning, mass-, dose- and count-based UMs are interlinked.
The value, meaning, usefulness and complexity of defining
and using (dose-based) UMs for the quantification of veterinary
AMU have been addressed before (25). At EU level, (23)
published a list of standardized Defined Daily Doses (DDDvet)
and Defined Course Doses (DCDvet) for pigs, poultry and cattle,
defined at the level of active ingredient and administration
route and based on the Summary of Product Characteristics
(SPC) for products authorized for that period in nine European
countries (26). Table 1 illustrates the variety of UMs that are
used. The choice of UM is highly dependent on the context (data
availability, resources, surveillance objectives, etc.).
When working with mass-based UMs, farm-level AMU can
appear to have improved by switching to medicinal products
with a lower dose rate, whereas the level of animal exposure to
antimicrobials may not have changed. Besides a lack of clarity
around which species was treated, this is one of the main
limitations of sales data. This is particularly true for some highest
priority CIAs for human medicine, such as third and fourth
generation cephalosporins, the use of which should be reduced
in veterinary medicine.
When basing the analysis on the PDDA, automatic data
input is only feasible if prescriptions are digitalized, which
may require additional investment. Moreover, if the prescription
does not specifically mention the dose in, for example, mg of
active substance per kg bodyweight or mg of active substance
per animal, the number of PDDA will require the data to be
transformed first, particularly if an in-feed or in-water regimen
is prescribed.
The UDDA can be calculated from administration data
(treatment written/electronic treatment logbooks) and will, by
definition, yield the most accurate reflection of the AMU
on the farm. Depending on individual country regulations,
working with the UDDA will often require the farmer/attending
veterinarian to have a role in data input, either as a sole provider
of the use data or for validating deliveries or prescriptions
provided by another party (vet, feed-mill, etc.) based on what was
actually used on farm. Count-based data, which are comparable
to UDDA-based data in terms of outcome, can be determined
from prescriptions, deliveries, as well as administration data and
need input from farmers on what was really used for how many
days and in how many animals.
If the intention is to be able to cross-check farm-level data
with sales data on a national level, which are almost always
mass-based, it must be possible to deduce the used mass of
antimicrobials from the farm-level AMU data.
Denominator: The Animal Population
No matter what type of UM is used, the UM needs to be
divided by a proxy for the targeted animal population to obtain
comparable results. Different types of population data can be
used, affecting the resulting indicator (25, 27).
The animal population is expressed as the mass of animals
present over a defined period. This is either described as the
biomass produced or the (average) mass of animals housed or a
combination of both.
Biomass Produced
This can be based on the actual mass of meat produced or on
the number of animals slaughtered multiplied by an estimated
or standardized weight (standardized weights are discussed
further in the text). For the calculation of farm-level AMU per
year, it must be kept in mind that a denominator based on
produced biomass does not reflect the true animal population
at risk of antimicrobial treatment if multiple production cycles
exist during that year. This is because slaughtered animals in
high producing livestock sectors (such as swine and poultry),
with multiple production cycles per year, have been at risk for
antimicrobial treatment during their lifespan which is shorter
than a year. This becomes evident when comparing AMU
with species with longer production cycles (such as cattle)
and/or countries where different farming practices apply (28).
Therefore, biomass produced is not an appropriate denominator
if the aim of a system is to calculate treatment incidences
or frequencies at farm-level (estimating true exposure to
antimicrobial treatment, see section about The Indicator). In
contrast, it can be a useful denominator if, for example, the
system aims for trend monitoring, e.g., for sector-level reduction
targets, as exemplified by successful AMU reductions achieved
in the UK (29). Also, if the aim is to compare AMU within
a livestock sector per production cycle the biomass can be an
appropriate denominator.
(Average) number or mass of animals at risk of treatment
The number of animals housed can be based on the maximum
capacity of the barns (the maximum number of animals present
on a farm), the number of animals present on average or
the number of animals present at a given moment. This
number of animals housed is then multiplied by an estimated
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or standardized weight in systems that use mass- and dose-
based indicators. In contrast to produced biomass, the (average)
number or mass of animals housed on farm is a suitable
representation of the animal population at risk of antimicrobial
treatment, hence, allows for calculation of treatment incidences
or frequencies. The more the (average) number or mass of
animals housed corresponds to the true number or mass of
animals present at the time of treatment, the more accurate
the calculation of exposure to AMU will be. To calculate this
figure, capacity numbers are the least precise and accuracy
increases when using stocking numbers, which need to be
measured regularly.
Several options exist to determine the standardized or
estimated weights that are used to establish the denominator
(Estimated) liveweight at treatment will yieldmore precise results
than an average weight (in a specific age category). For many
animal categories, it is known that most antimicrobial treatments
occur in the early stages of the animal’s life (30–32). The
estimated weight at treatment can be standardized, as suggested
for example by EMA (EMA, ESVAC reflection paper 2013) and
estimated standardized weights are applied in many countries
(e.g., Belgium, the Netherlands, Denmark, United Kingdom).
However, due to differences in production systems between
countries and farms, animal weights at treatment might differ
substantially and standardized weights may therefore be country-
and livestock sector-specific. The estimated weight at treatment
can also be determined based on age of the animal and a
corresponding growth curve. This method will increase workload
but will more accurately represent the animal liveweight at risk
of antimicrobial treatment and will thus lead to more precise
characterization of AMU.
For count-based systems, no weight is needed as either the
UM is not reflecting the individual animals (i.e., number of farms
using the drug is the UM) or the number of animals at risk is
used in the calculation method. Kasabova et al. recently showed
that differences in the weights used to calculate the population at
risk have a substantial impact on the calculated AMU (31).
If the number of days at risk (i.e., the number of days each
animal is present at the farm) is included in the denominator, i.e.,
the time interval during which AMU is assessed, the result will be
a treatment incidence (33). The period at risk of treatment should
correspond to the animal population at risk and to the period
during which the numerator data are collected. As an example,
if considering AMU over 1 year, the corresponding period at
risk should be 1 year. In Denmark and Belgium 100 animal-days
are used which is a proxy for the percentage of time an average
animal is treated or the percentage of animals that are treated
daily with one substance. In the Netherlands, the number of days
an animal was treated in a year is calculated, which might be
particularly useful for animals, such as dairy or beef cattle, with a
longer production cycle.
The Indicator
The indicator is a technical unit used to quantify exposure to
antimicrobials. Depending on the UM and the other parameters
included in the calculation, different indicators will be obtained
(23, 25, 27, 34). Tables 1, 2 illustrate the variety of indicators
used in the different existing monitoring systems. Use of a mass-
, dose-, or count-based UM will, respectively, lead to a mass-
based indicator, such as mg/kg biomass or mg/PCU (population
correction unit), a dose-based indicator, such as number of
DDDA/1,000 animals produced or number of DDDA/animal
year, or a count-based indicator, such as the treatment frequency.
As indicated in Table 1 most indicators included here are
dose-based, a minority are mass-based, and some count-based
indicators are calculated.
The choice of the indicator impacts on the interpretation of
AMU monitoring results. However, deciding on which AMU
indicator to use can be complex, given the range of existing
options. The guidelines on the AACTING website highlight
various aspects to consider when deciding which indicator to use
for AMUmonitoring.
Benchmarking
Benchmarking of AMU refers to the comparison of a party’s
AMUwith the AMUof similar parties (the reference population),
given that AMU for all parties is quantified in a comparable
manner. To the authors’ knowledge, benchmarking is currently
carried out—or planned to be carried out as soon as good
quality data are available and a methodology is developed—in 12
countries, encompassing 20 AMUmonitoring systems (Tables 1,
2). Most existing AMU monitoring systems benchmark farmers;
three systems benchmark veterinarians (Table 1).
Benchmarking is performed with a certain frequency (for
example, twice a year) and takes AMU within a certain time
interval (for example, the preceding year) into consideration.
The shorter the production cycle of the animal species or animal
category for which the AMU is benchmarked, the greater the
relevance of a high benchmarking frequency. The time interval
should depend on the expected influence of recurring events
(for example, seasonal influences) and needs to find a balance
between allowing for frequent reporting of the benchmarking
indicator (short time interval) and obtaining a longer-term view
of AMU (long time interval). A longer time interval may be
useful to achieve more sustainable use practices but could lead
to issues with perceived “fairness” or “relevance” of the score
if antimicrobial use distant in time still impacts the current
benchmarking result.
Various aspects of AMU can be benchmarked using different
indicators. A starting point at farm-level is the total AMU
on the farm (per species or, if different age/weight categories
of a species are present, per production stage). Furthermore,
various qualitative aspects of AMU can be benchmarked, e.g.,
the use of certain classes or categories of (critically important)
antimicrobials, the type of treatment [e.g., veterinary medical use
vs. non-veterinary medical use (35)], the route of administration
(e.g., oral, parenteral, and intramammary). It might be advisable
not to benchmark too many aspects, as multiple benchmarking
results for a single species (category) might become confusing
and end up being counterproductive, especially if the results
appear contradictory.
The reference population can be based on geography (e.g.,
country, region), economic traits (e.g., sector, quality assurance
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TABLE 2 | Overview of count- and dose-based indicators calculated by different systems for analyzing AMU at farm-level.
Countrya System(s) Typeb Indicatorc Formula of indicatorc,d
Austria PHAROS Dose based DDDvet/kg/year mg AB used/DDDvet × n animals at risk × kg standard weight
PHD Count based TH/UTH n treated herds/n untreated herds
Belgium All Dose based TD100 (mg AB used/DDDAbel × kg animal at risk× n days at risk)× LA−
factor× 100
Sanitel-Med Dose based* Contract score
[(
% green ACU÷ 2
)
−
(
% red ACU÷ 2
)
+ 0, 5
]
× 100
Canada CIPARS Count based pp TF|H n treated flocks | herds/total n flocks | herds
Dose based DDDvetCA/PCU
(
Milligrams active ingredient/DDDvetCAmg/kg/day
Total animals ×Standard weight at treatment
)
DDDvetCA/1000 AD
(
Milligrams active ingredient/DDDvetCAmg/kg/day
Total animals ×standard weight ×days at risk
)
× 1, 000
Switzerland IS ABV Count based ATI n treated animals × n treatment days × n substances/n animals per year
Dose based Treatment intensity (mg AB used/DDDvet or DDDCH × kg animal at risk× n days at risk) x 100
SuisSano | Safety+ Count based ATI n treated animals × n treatment days × n substances/n animals per year
*LA Factor*HPCIA Factor
Dose based DCDvet/animal/year
(
mg AB used/DCDvet × standard weight× n animals at risk per year
)
DCDCH/animal/year
(
mg AB used/DCDCH × standard weight× n animals at risk per year
)
The Czech Republic Q VET pigs Dose based ADD/100 animal-days
Germany HIT Count based Treatment frequency n treated animals × n treatment days × n substances/n animals per day
QS Count based Therapy index n treated animals × n treatment days /total animal capacity
VetCAb Count based Treatment frequency n treated animals × n treatment days × n substances/total animal capacity
Denmark VetStat Dose based ADD/100 animal-days (mg AB used /
technical daily dosage ( ADD ) × kg animal at risk × n days at risk) × 100
Finland AH ETT poultry Count based pp TF n treated flocks/total n flock
France CLIPP Count based IFTA
∑z
t=1 (n treament days× n substances)t/
n days in reproduction cycle or rearing period
With t = the number of treatments
GVET Count based Treatments/animal
∑z
t=1(n treated animals)t/n animals at risk
With t = the number of treatments
Treatment days/animal
∑z
t=1(n treated animals × n treatment days)t/n animals at risk
With t = the number of treatments
GVET | INAPORC Dose based CD/animal mg AB used/DCDAFR × kg animals at riskn animals at risk
DD/animal mg AB used/DDDAFR × kg animals at risk/n animals at risk
RefA²vi Dose based DDDFR/kg slaughtered mg AB used/DDDFR/kg animals slaughtered
DCDFR/kg slaughtered mg AB used/DCDFR/kg animals slaughtered
VEAL Count based Treatments/animal
∑z
t=1 (n treated animals)t/n animals at risk
With t = the number of treatments
Treatment days/animal
∑z
t=1 (n treated animals × n treatment days)t/n animals at risk
With t = the number of treatments
Dose based ALEA mg AB used/DCDAFR × n animals slaughtered × standard weight
Italy ClassyFarm Dose based DCDIT/animal/period mg AB used /DDDAIT × kg animals at risk
The Netherlands SQS/SDa Dose based DDDANL/yr kg treatable animals/kg animals at risk
Der VBI AUC of ln-transformed ratio DDDAnl/yr and applicable thresholds over all
1-on-1-farms
Sweden SPMA Count based pp TF n treated flocks/total n flocks
The United Kingdom BEIC Count based ADD/100 animal-days
BPC-AS Mass based mg/kg mg AB used/kg animals at risk
eMB-Pigs Mass based mg/kg mg AB used/kg animals at risk
SSPO Mass based mg/kg mg AB used/kg animals at risk
aAT, Austria; BE, Belgium; CA, Canada; CH, Switzerland; CZ, the Czech Republic; DE, Germany; DK, Denmark; FI, Finland; FR, France; IT, Italy; NL, the Netherlands; SE, Sweden; UK,
United Kingdom.
b*Derived from (dose-based) farm-level benchmarking results.
cADD, animal daily dose; ATI, (animal treatment index); ALEA, Animal Level of Exposure to Antimicrobials; CD, course dose; DD, daily dose; DCDCH, defined daily dose for animals as
defined for Switzerland; DCDIT , defined daily dose for animals as defined for Italy; DDDFR/DCDFR, defined daily/course dose for animals as defined for France; DDDANL, defined daily
dose for animals as defined for the Netherlands; DDDvet/DCDvet, defined daily/course dose for animals as defined by EMA (EMA, 2015); DDDvetCA, defined daily dose for animals as
defined for Canada; IFTA, Index of Frequency of Treatments with Antibiotics (number of treatment days related to rearing period); PCU, population correction unit, as defined by EMA
(EMA, 2011); pp, proportion; TF|H, treated flocks | herds; UTH, untreated herds; VBI, Veterinary Benchmark Indicator.
dAB, active substance of an antibiotic; ACU, animal category unit, representing a single farm-level benchmarking result, with green being low use (= below the lower threshold as defined
in the specific system) and red high use (above the higher threshold as defined in the specific system); AUC, area under the curve; DDDAbel , defined daily dose for animals defined
at Belgian national level; LA-factor, long-acting factor; the technical daily dosage is based on the ADD principle, where each registered antimicrobial product in Denmark is assigned a
specific dosage.
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scheme), animal traits (e.g., species, age/weight category), or
simply on selection criteria and the willingness of parties to co-
operate (e.g., in a research study). In practice, combinations often
occur, e.g., benchmarking within a group of farms adhering to a
certain quality assurance scheme and raising fattening pigs. In
systems with only partial coverage, special attention should be
paid to defining the reference group to avoid drawing conclusions
based on a few farms or particular farm types.
The more relevant the chosen reference group, the more
practically useful benchmarking will be. For instance, in veal
calves, it might be decided to benchmark among veal calf farms
in general. Making a further distinction between production
stages/types, for example starters and finishers or rosé and
white veal farms (if applicable) might add important nuances to
the result (36). However, defining too many reference groups,
each with their own thresholds for (un)acceptable use, can be
counterproductive. For example, if reference groups are chosen
according to farm management characteristics (e.g., weaning age
in pigs, breed), high use caused by using a vulnerable breed that
is more prone to infectious diseases might be deemed acceptable
by the benchmarking system.
Two types of benchmarking can be distinguished: “dynamic”
and “fixed” benchmarking. We define “dynamic benchmarking”
as a methodology where the benchmarking result depends on
the distribution of AMU in the reference population. Ranking
a party within the reference population (e.g., farm X is at
the 40th percentile) is one form of dynamic benchmarking.
Another is using one or more threshold values derived from
the distribution of AMU in the reference population (e.g., the
median and the 75th percentile) and categorizing farms relative
to these thresholds. In contrast, “fixed benchmarking” uses
reference values that do not (always) reflect the distribution of
AMU in the reference population. Such threshold value(s) are
typically set for a long(er) period. Generally, the distribution
of AMU in the reference population is used to initially set or
adjust the fixed threshold(s). However, “politically” motivated
thresholds are also used, i.e., thresholds that are not related to
the current distribution of use but state a fixed reduction target,
e.g., reduction by 20% over a certain period.
Dynamic benchmarking is applied, for example, in Belgium
and Germany, and the systems involved apply two threshold
values. In Denmark, fixed benchmarking with one threshold is
applied. This is also the case in the Netherlands, the latter having
evolved recently from a fixed benchmarking method using two
threshold values to now using only one. In Belgium, the pig sector
has recently started working with fixed benchmarking with two
threshold values.
A farm-level AMU distribution is in most cases right-skewed,
with a long tail toward the high-user end of the distribution
(22). For this reason, using the arithmetic mean AMU as a
reference or threshold value may not be ideal. Therefore, the
median value is often used as the lower threshold, for example, in
Belgium and Germany. As the upper threshold, the third quartile
(75th percentile) is used in Germany and the 90th percentile
in Belgium.
Fixed benchmarking does not mean the threshold values will
never change. Adaptations of thresholds according to changes
in use or changes in policy are advisable. As described above,
the Netherlands recently revised their threshold values, as the
original benchmark values were no longer deemed to provide
enough incentive to further reduce AMU in several livestock
sectors (37). In Denmark, the threshold values have been revised
five times since they were launched in 2010 (21). Furthermore, a
differentiated benchmarking strategy was implemented in 2016,
with certain antimicrobial classes being weighted with higher
factors in the quantification of AMU in this country.
An advantage of dynamic benchmarking is that it is more
difficult for the benchmarked parties to circumvent prudent
usage policies by strategic changes in their AMU to comply
with the threshold values. Dynamic values ensure that constant
pressure is sustained for parties to keep reducing their AMU.
However, this might have a discouraging effect, as reducing
AMU does not necessarily mean that a party will reach a
level below the threshold, because the threshold may have been
lowered as well. A challenge of dynamic benchmarking is that
data validation needs to be finalized and the data need to be
fixed before benchmarking is applied. This avoids the reference
group changing over the course of the process, as parties with
incorrect data may be excluded (and later re-included) from
the reference group during benchmarking periods, which would
result in different benchmarking thresholds. This shows that
working with dynamic thresholds can be technically harder and
analyzing trends is more challenging. As a result, using dynamic
thresholds in the design and communication of antimicrobial
policy measures is generally more complex.
When applying fixed benchmarking, two thresholds might
be set. With two thresholds, three zones are created: a zone
with “desirable or accepted use,” with AMU below the lower
threshold; an “attention” zone, with AMU between the lower
and the upper threshold and an “action” zone, with AMU
above the upper threshold (see Supplementary Figures 1, 2).
This approach allows the system to focus on the highest users of
antimicrobials, yet allows the group of “elevated attention” users
to be identified and alerted.
Ultimately, using only one fixed threshold value (per animal
species or category) is the most straightforward approach (i.e.,
the level of AMU is categorized as acceptable or not) and
administratively and technically the least complex. As shown in
the Netherlands and in Denmark, this is particularly advisable
if the distribution of the AMU in the reference population
is generally low and less right-skewed. Adaptation to such a
threshold will in this case not be such a problem. If this is not
the case an “attention zone” might be useful, with farms within
this zone receiving a warning but without warranting immediate
action. The consequences of setting the level of a threshold, in
terms of number of farms exceeding the threshold(s) and the
corresponding workload, should be kept in mind.
For the purpose of AMS and to encourage behavioral
changes, benchmarking is particularly relevant if the outcome
has consequences for the benchmarked party. Across countries,
different risk management measures or interventions are
triggered when thresholds are exceeded. Examples include
the requirement to draw up action plans to reduce AMU,
detailing additional measures that will be taken to reduce
disease incidence, additional veterinary or inspection visits,
compulsory advice to be obtained from an external party, fines,
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or exclusion from quality schemes. Furthermore, more corrective
measures could be foreseen if AMU levels remain above a certain
threshold for an extended period. Ultimately, animals or their
products could be considered unfit to enter the food chain.
On the other hand, parties with prudent and responsible use
might also be rewarded. Such positive consequences might be
social, e.g., making the good results of farms visible through
certification or other “signs of recognition,” or financial, through
for example a bonus for good results. However, very low or
zero use should be validated, as use might not have been
correctly reported. It is important to note that the goal should
be to use antimicrobials prudently, which should lead to an
overall reduction in AMU. This should be predominantly
achieved by only using antimicrobials when necessary to ensure
animal welfare.
Parties should be granted adequate time between receiving a
benchmarking result and the deadline for subsequently achieving
a reduction in AMU. For example, if benchmarking results are
available every trimester, it is unfeasible to require a reduced
AMU by the next reporting cycle when a single production cycle
lasts 6 months. In the interests of fairness, it should also be
possible to appeal against a result for a short period after receiving
the benchmarking result.
The success of benchmarking in terms of AMS will increase if
the analysis and benchmarking methodology are transparent and
clearly communicated to the affected parties.
Considering the responsibility of veterinarians for prescribing
antimicrobials and therefore directly influencing AMU in
animals, benchmarking veterinarians is an important option
from an AMS perspective. Depending on the country and its
legislation, it is not necessarily the AMU of a veterinarian that
is being benchmarked but rather their “antimicrobial prescribing
behavior.” For convenience, we will denote this as “AMU of
veterinarians” for the remainder of this paper. Similar definitions
and principles apply for benchmarking the AMU of veterinarians
as outlined above for benchmarking the AMU of farmers.
However, benchmarking the AMU of veterinarians is more
complex. The benchmarking score of a veterinarian needs to
be calculated from the AMU of multiple farms. This can be
challenging, as differences exist between veterinarians in terms
of the number and characteristics of the farms he or she is
responsible for. In addition, compared to benchmarking farmers,
who are (legally) responsible for actions taken regarding the
health of animals on their farm, it is more difficult to make
veterinarians feel responsible for the AMU on a farm if it is
being serviced by other vets, i.e., if there is no strict one-to-
one relationship.
Usage results may be biased due to different health status and
size of farms serviced by a practice. The Netherlands was the
first country to adopt benchmarking of veterinarians. The Dutch
veterinary benchmark indicator (VBI) calculates the probability
of the farms, for which a certain veterinarian is responsible,
falling within the action zone [i.e., above a certain AMU
threshold; (38, 39)]. This methodology is now under revision
(22, 37). In 2019, the Belgian “Sanitel-Med” system launched
its benchmarking of veterinarians. Two scores are applied: (1) a
contract score, expressing, for farms on which the veterinarian
is the designated “herd vet,” the distribution of animal categories
falling within the “low,” “attention,” and “high” AMU zones in
the benchmarking at farm-level; (2) a management score. The
latter expresses the proportion of the total AMU of a veterinarian
that was used at farms where the veterinarian was not the
designated herd veterinarian. Austria also recently implemented
a benchmarking system for veterinarians. Switzerland and France
have tools that may be used in the future to apply benchmarking
of veterinarians, but the protocols are not yet established
and implemented.
Benchmarking of AMU of farms and/or veterinarians can be a
powerful tool in reducing AMU as shown in Denmark, Germany
and the Netherlands (21, 22, 40).
Reporting
Within the scope of this review, reporting refers to the process
of providing feedback about farm-level AMU to the farmer or
other parties. Such a process is critical, especially in terms of
AMS. Of the four processes discussed here, reporting is the most
subjective one, and needs to be adapted to the target audience.
Consequently, discussing the value of different reporting formats
is beyond the scope of this paper. Examples are provided only to
illustrate some of the possible options.
Three types of target groups can be broadly distinguished:
farmers and veterinarians, regulators and stakeholders
(government, industry, sector organizations, farm assurance
schemes) and the general public/consumers. In terms of AMS,
farmers and veterinarians are the group most suited for receiving
individual benchmarking results. Summarizing reports, typically
not containing individual results, are more useful for a wider
audience. The latter reports focus on general trends, achieving
policy targets, comparing AMU among different animal species,
categories, or other subgroups, etc. Several countries have been
publishing reports of antimicrobial sales data for many years,
increasingly including AMU data and sometimes AMR data
as well [examples from countries in the AACTING network
(21, 22, 29, 41–44)]. Reports for regulators can fall in either of
the two categories, i.e., the individual party and the anonymous
summary reports. In Belgium, yearly summarizing reports,
without individual farm results, are also made available for some
quality assurance schemes. Regardless of the purpose of data
collection and the report type, the ownership of the data and
their confidentiality must be defined and strictly adhered to. Any
communication of results to third parties must be approved by
the data owner. Summary results such as general trends by sector
can, however, generally be published. Data ownership by the
government is another option.
In terms of policy making and auditing, reporting of farm-
specific results should be periodic, i.e., at pre-defined times and
for all farms. In the Netherlands, the “SDa” reports analyses
on AMU to regulators, policy makers and the general public,
while the quality systems report, in parallel, to their farmer
members. Private quality assurance systems of the monitored
livestock sectors report results and provide feedback to individual
farmers about their AMU. Broiler farmers, for example, receive
a report every 3 months in which several aspects of their
AMU are compared to sector averages. If a farmer’s AMU is
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considered too high, measures are required to reduce use. In this
respect, it might be interesting to additionally provide means of
evaluating the result in real-time (for example through an online
portal), especially if the frequency of periodic reporting is low
(for example once a year) and the animals’ replacement rate is
relatively high.
Reporting will have the greatest effect when the (quantitative)
information is given in relation to a reference population,
hence as a benchmarking result. Showing a specific farm’s AMU
within a distribution of AMU within that sector/animal category
makes comparisons easier and more illustrative for farmers
(Supplementary Figure 1). Moreover, this could lead to “social
pressure,” known to be one of the five cues for changing human
behavior (45). Most systems that perform benchmarking also
report the results to all the parties involved (Table 1).
In addition to the quantitative use results, reports may contain
guiding information, such as directives, data on farm trends and
more detailed qualitative analyses, creating more insight into
farm-level AMU (Supplementary Figure 2). In the Netherlands,
antimicrobials are classified as either first, second or third choice
antimicrobials, depending on resistance inducing effects and
importance to human health. A similar system exists in Belgium,
using color codes (yellow, orange, and red antimicrobial classes,
respectively). The use of different choices of antimicrobials is
also reported to individual farmers. Other aspects of interest to
report to farmers could include use of group treatments, use of
medicated feed containing antimicrobials, use of intramammary
tubes, age at treatment, indication for treatment, etc.
Ultimately sustained behavioral changes in veterinarians and
farmers are needed to establish prudent AMU. Invoking
behavioral changes is complex and dependent on the
target audience. Speksnijder and Wagenaar described how
sociopsychological models can provide insight into a farmers’
and veterinarians’ behavior regarding AMU practices and how
behavioral changes can be motivated (46). Several studies report
that veterinarians perceive their main role as a service provider,
they do not feel a demand from their farmers for advice (47–49).
Insights obtained from sociopsychological models might also
support veterinarians in their advisory role toward improving
a farmer’s management (46). Communicating best practices
to farmers as well as veterinarians might be a helpful tool to
encourage farmers and veterinarians to reduce AMU (50).
DISCUSSION
This overview shows a very large variety across systems, especially
at the level of analysis (choice of numerator, denominator and
indicator). As AMU reduction figures for several countries have
proven the principle of implementing farm level monitoring
might be a more defining factor for success than the actual
methods used. Furthermore, each system has its limitations,
perhaps not so much in design as in execution: the results
(calculated AMU) largely depend on the degree to which the data
were provided to the system(s) correctly and in a timely manner.
Hence, it could be argued that aiming for harmonization across
systems is not only unfeasible but also unnecessary.
Nonetheless, a desire to compare, essentially between similar
sectors in different countries, does exist (13). In this regard,
it is remarkable that almost all systems deploying farm-level
benchmarking in partial or full coverage systems use an
indicator that reflects the (true) exposure of animals to AMU,
by calculating a treatment incidence or treatment frequency
(Table 1). It is for this reason that an indicator reflecting the
number of treatment days out of 100 days present on the
farm has been specifically brought forward in the AACTING
guidelines, published in the scope of the AACTING project,
and with the aim of assisting parties in setting up systems for
monitoring of farm-level AMU (see www.aacting.org/aacting-
guidelines). Although, as noted above, it is clear that various
other indicators are just as valuable, the value of this particular
indicator lies in the fact that its outcome is a meaningful
parameter for the farmer and veterinarian, and that it is a
flexible indicator, which makes it possible to calculate back to
mg/kg or to transform to a treatment frequency (when using
the UDD instead of the DDD). As a secondary effect, these
guidelines might be a step toward more harmonized approaches
for farm-level AMU monitoring. It should be recognized that
there is potential for more harmonization. Currently, a lack
of harmonization is one of the factors that limits comparisons
of AMU between farms within countries and comparisons of
farm-level AMU data between countries, even though such
comparisons are important for improving AMU practices (25,
51). More harmonized approaches to monitoring AMU at farm-
level will improve understanding, communication, and sharing
knowledge regarding AMU monitoring and benchmarking. Yet,
even if using harmonized usage indicators, comparing systems
in different countries might be seriously limited by variations in
health and husbandry conditions, for example, the production
cycle length of animals, availability of medical products, and
regulations. It remains the responsibility of the parties aiming for,
or performing any, comparisons of systems to carefully address
the differences between them, which will not be resolved by
choosing a uniform indicator.
Apart from bringing forward the usefulness of a specific type
of indicator for monitoring farm-level AMU, the AACTING
guidelines had the aim of providing useful information as how
to organize the data collection, what to take in consideration
when choosing a methodology for analysis, principles of
benchmarking, and critical factors for reporting. The rationale
for many of the points raised in the guidelines is provided
in this overview. It is therefore advised to jointly consider
both documents.
In conclusion, quantifying AMU at the farm-level represents
an important step toward AMS, as mirrored in the ESVAC
vision for 2016–2020. Recently, an increase has been observed in
the number of countries developing AMU quantifying systems.
An important aim of the AACTING consortium is to provide
information about existing systems and support in designing
new systems or revising existing systems. In this paper, we
investigated the necessary components of such systems and
described the available options, taking into consideration a
selection of systems that currently exist. Based on this overview
and the combined expertise of the international authors,
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we proposed a set of guidelines on the collection, analysis,
benchmarking and reporting of AMU. These guidelines represent
a relevant tool for entities planning to establish new farm-level
systems for quantifying AMU and shall ideally contribute to the
standardization of methodologies.
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DEFINITIONS AND ABBREVIATIONS
AMU: Antimicrobial use.
AMR: Antimicrobial resistance; the ability of microorganisms of
certain species to survive or even to grow in the presence of
a given concentration of an antimicrobial agent that is usually
sufficient to inhibit or kill microorganisms of the same species
(52). Only acquired resistance is considered within the scope of
this publication.
Benchmarking: The comparison of a party’s AMUwith the AMU
of similar parties (the reference population), given that AMU for
all parties is quantified in a comparable manner.
AMS: Antimicrobial stewardship; AMS is aiming for prudent
and appropriate AMU, which is defined by the World
Health Organization (WHO) as “use of antimicrobials, which
maximizes therapeutic effect and minimizes the development of
antimicrobial resistance”; according to the OIE, AMS consists of
“a set of practical measures and recommendations intended to
prevent and/or reduce the selection pressure of antimicrobial-
resistant bacteria in animals” (53). This also includes preventive
measures to avoid antimicrobial use.
CIA: Critically important antimicrobials as defined by theWHO.
These antimicrobials are considered critically important for
human health according to two main specific criteria (54).
Party: Any person, group of persons or organization involved in
any of the processes of data collection, analysis, benchmarking,
etc., such as farmers, herd managers, veterinarians, pharmacies,
researchers, and system administrator(s).
DDDA: Defined daily dose animal; the assumed average dose of
an antimicrobial per kg animal body weight by animal species.
The EU standard is the DDDvet (24).
DCDA: Defined course dose animal; the assumed average dose of
an antimicrobial per kg animal body weight per treatment course
for a specific animal species. The EU standard is the DCDvet
(EMA, 2015).
UDDA: Used daily dose animal; the actual dose used of an
antimicrobial per kg animal body weight of active substance for a
specific animal species.
PDDA: Prescribed daily dose animal; the dose of an antimicrobial
(or active substance) that is on average prescribed per kg animal
body weight per day for a specific animal species.
UM: Unit of measurement; the unit in which the amount of
antimicrobials used is expressed.
Indicator: The parameter quantifying use of antimicrobials,
generally calculated as “number of units of measurements” (the
numerator) divided by the “animal population” to standardize
the use data (the denominator).
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